Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 39931-77-6 | MDL No. : | MFCD00006411 |
Formula : | C9H11NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RPWXYCRIAGBAGY-UHFFFAOYSA-N |
M.W : | 165.19 | Pubchem ID : | 96490 |
Synonyms : |
Ethyl 3-pyridylacetate
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 44.91 |
TPSA : | 39.19 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.86 cm/s |
Log Po/w (iLOGP) : | 1.58 |
Log Po/w (XLOGP3) : | 0.63 |
Log Po/w (WLOGP) : | 1.19 |
Log Po/w (MLOGP) : | 0.71 |
Log Po/w (SILICOS-IT) : | 1.85 |
Consensus Log Po/w : | 1.19 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.37 |
Solubility : | 7.09 mg/ml ; 0.0429 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.03 |
Solubility : | 15.5 mg/ml ; 0.0938 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.9 |
Solubility : | 0.207 mg/ml ; 0.00125 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.7 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | With dmap; bis(η3-allyl-μ-chloropalladium(II)); 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl In 1,3,5-trimethyl-benzene at 140℃; for 20 h; Inert atmosphere | General procedure: after standard cycles of evacuation and back-filling with dry and pure nitrogen, an oven-dried Schlenk tube equipped with a magnetic stirring bar was charged with Pd source (see Table 1, Table 2, Table 3 and Table 4), ligand (see Table 1, Table 2, Table 3 and Table 4), N,N-dimethylpyridin-4-amine (DMAP, see Table 1, Table 2, Table 3 and Table 4), and ethyl potassium malonate (see Table 1, Table 2, Table 3 and Table 4). The tube was evacuated and backfilled with argon (this procedure was repeated three times). Under a counter flow of argon, aryl halide (see Table 1, Table 2, Table 3 and Table 4) and solvent (see Table 1, Table 2, Table 3 and Table 4) were added by syringe. The tube was sealed and stirred at room temperature for 10 min. Then the tube was connected to the Schlenk line, which was full of argon, stirred in a preheated oil bath (140-150 °C) for the appointed time (20-25 h). Upon completion of the reaction, the mixture was cooled to room temperature and diluted with diethyl ether, and the yields were determined by gas chromatography using 1,3-dimethoxybenzene as the internal standard. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | for 6 h; Reflux | To a solution of 3-pyridylacetic acid hydrochloride (51) (12.00 g, 69.19 mmol) in EtOH (120 mL) was added concentrated H2SO4 (5 mL) and the solution was heated at reflux (6 h). The reaction mixture was concentrated in vacuo and diluted with EtOAc (200 mL). The EtOAc layer was washed with saturated aqueous NaHCO3 (3 x 200 mL) and brine (2 x 200 mL), and dried (Na2SO4). The crude product was purified by flash column chromatography (SiO2; 4:5 EtOAc/hexanes) to give the desired product (10.67 g, 93percent) as a pale yellow oil. Rf 0.37 (4:1 EtOAc/hexanes). 1H NMR (CDCl3) δ 1.26 (t, J = 7.2 Hz, CH2CH3), 3.63 (s, CH2C5H4N), 4.17 (q, J = 7.2 Hz, CH2CH3), 7.25-7.30 (m, C5H), 7.64-7.67 (m, C4H), 8.45-8.59 (m, C2H, C6H). 13C NMR (CDCl3) δ 13.7 (CH2CH3), 38.0 (CH2C5H4N), 60.7 (CH2CH3), 122.9 (C5H), 129.5 (C3H), 136.4 (C4H), 148.0 (C2H or C6H), 149.9 (C6H or C2). |
[ 39998-25-9 ]
Methyl 2-(pyridin-3-yl)acetate
Similarity: 0.96
[ 1174229-72-1 ]
Ethyl 2-(6-aminopyridin-3-yl)acetate
Similarity: 0.89
[ 90610-06-3 ]
Methyl 2-(6-methylpyridin-3-yl)acetate
Similarity: 0.86
[ 29800-89-3 ]
Methyl 2-(pyridin-4-yl)acetate
Similarity: 0.85
[ 39998-25-9 ]
Methyl 2-(pyridin-3-yl)acetate
Similarity: 0.96
[ 1174229-72-1 ]
Ethyl 2-(6-aminopyridin-3-yl)acetate
Similarity: 0.89
[ 90610-06-3 ]
Methyl 2-(6-methylpyridin-3-yl)acetate
Similarity: 0.86
[ 29800-89-3 ]
Methyl 2-(pyridin-4-yl)acetate
Similarity: 0.85